News

The Latest Industry News

nonalcoholic fatty liver disease

T2D and Non-Alcoholic Fatty Liver Disease (NAFLD)

Posted on May 30, 2024

Diabetes is a serious condition that not only causes hormonal and blood sugar imbalances, but can also damage nerves, blood vessels and other organs. Common side effects of diabetes include poor circulation, non-healing foot and leg ulcers, vision loss, kidney damage and liver disease.   At Texas Diabetes & Endocrinology (TD&E), our board-certified endocrinology experts treat diabetes and help […]

Read More

What’s the link between osteoporosis and the gut biome? 

Posted on May 14, 2024

May is Osteoporosis Awareness Month. This condition, marked by severely weakened bones, is one that our board-certified endocrinologists treat daily here at Texas Diabetes & Endocrinology (TD&E). While it is commonly known that calcium helps to strengthen bones and protect against osteoporosis, new research shows that good gut health (or the gut biome) can also play a large […]

Read More

Overcoming the Odds: T2D Patient’s Journey to Marathon Success

Posted on April 29, 2024

Adopting the philosophy of ‘mind over matter’ can have a powerful impact on many aspects of life. In many instances of illness or injury, people can often conjure up herculean efforts to boost their physical and mental well-being, alongside therapeutic intervention, to overcome a medical or health challenge.  This is something that our 52-year-old patient […]

Read More
CGM

FDA Approves New OTC Continuous Glucose Monitor (CGM) 

Posted on April 18, 2024

A continuous glucose monitor (CGM) has typically only been available via prescription, until now.  Recently, the Food and Drug Administration (FDA) approved over-the-counter (OTC) sales of a CGM known as Dexcom’s Stelo Glucose Biosensor System. This is good news not only for those with diabetes, but also for those who want to support a healthier lifestyle […]

Read More